Gene · 2217
Papers4,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-dose infusion of engineered viral receptor binding domain confers rapid and durable protection against viral infection. | Commun Biol | 2025 | 40855361 | PubTator, text mining | PubMed |
| Microbiota-derived corisin accelerates kidney fibrosis by promoting cellular aging. | Nat Commun | 2025 | 40855053 | PubTator, text mining | PubMed |
| Long-Circulating Nanobody Confers Durable Prophylaxis against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection. | Adv Nanobiomed Res | 2025 | 40851835 | PubTator, text mining | PubMed |
| Mesothelin-directed protein-drug conjugates for mesothelin-low solid tumor therapy. | Nat Commun | 2025 | 40849430 | PubTator, text mining | PubMed |
| FcRn inhibitors for myasthenia gravis. | Cochrane Database Syst Rev | 2025 | 40843812 | PubTator, text mining | PubMed |
| FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia. | Antibodies (Basel) | 2025 | 40843677 | PubTator, text mining | PubMed |
| Model-Informed Optimal Dosing of Anti-CD47 Antibody Using Target-Mediated Drug Disposition Model. | Clin Transl Sci | 2025 | 40841178 | PubTator, text mining | PubMed |
| Milk-Derived Extracellular Vesicles and microRNAs: Potential Modulators of Intestinal Homeostasis. | FASEB J | 2025 | 40838537 | PubTator, text mining | PubMed |
| The efficacy and safety of efgartigimod for refractory myasthenia gravis: a systematic review and meta-analysis. | Eur J Med Res | 2025 | 40830529 | PubTator, text mining | PubMed |
| Real-World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape. | J Peripher Nerv Syst | 2025 | 40826893 | PubTator, text mining | PubMed |
| Emerging trends in synthesis, characterization, and mechanism of action of antibody-drug and antibody-nanoparticle conjugates. | Discov Nano | 2025 | 40824329 | PubTator, text mining | PubMed |
| The FcRn from gene to protein and function: comparison between species. | Front Immunol | 2025 | 40821792 | PubTator, text mining | PubMed |
| Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart. | Nat Commun | 2025 | 40819168 | PubTator, text mining | PubMed |
| Targeting the neonatal Fc receptor (FcRn) in hematologic conditions with a focus on warm autoimmune hemolytic anemia. | Blood Rev | 2025 | 40813187 | PubTator, text mining | PubMed |
| Immunoglobulin G Receptors (FcγR), in Addition to Target-Antigen and Neonatal Fc Receptor (FcRn), Influence Rituximab Pharmacokinetics. | Clin Pharmacokinet | 2025 | 40810921 | PubTator, text mining | PubMed |
| Case Report: Treatment of delayed tremor episodes in a patient with DPPX antibody encephalitis. | Front Immunol | 2025 | 40808961 | PubTator, text mining | PubMed |
| Redefining Treatment Paradigms in Thyroid Eye Disease: Current and Future Therapeutic Strategies. | J Clin Med | 2025 | 40807149 | PubTator, text mining | PubMed |
| Pregnancy reduces COVID-19 vaccine immunity against novel variants. | NPJ Vaccines | 2025 | 40804265 | PubTator, text mining | PubMed |
| Efgartigimod as Add-On Treatment in Refractory Guillain-Barré Syndrome: A Case Report. | Eur J Neurol | 2025 | 40799081 | PubTator, text mining | PubMed |
| The evolving landscape of thyroid eye disease: present and future. | Eur J Endocrinol | 2025 | 40794607 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2217/papers?page=17